Activation of Hh signaling in cancer can occur via several mechanisms, such as ectopic production of Hh ligands, somatic mutations in the Hh pathway components, Ptch1, Smo, Sufu, and/or amplifications of the Hh transcription factor Gli1 [5]. Here, PTCH1 is linked to cancer.